← FDA Drug Approvals (Drugs@FDA)

OCREVUS ZUNOVO

BLA · Biologics License Application · Sponsor: GENENTECH INC · Approved 2024-09-13

Drug application

FDA Application #

BLA761371

Application type

Biologics License Application

Brand name

OCREVUS ZUNOVO

Generic name

OCRELIZUMAB AND HYALURONIDASE

Active ingredients

OCRELIZUMAB AND HYALURONIDASE-OCSQ

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

GENENTECH INC

Manufacturer

Genentech, Inc.

First approval

2024-09-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown